Status:
ENROLLING_BY_INVITATION
Towards Personalized Nutrition With SCAPIS2-HOME
Lead Sponsor:
Chalmers University of Technology
Collaborating Sponsors:
Göteborg University
Umeå University
Conditions:
Cardiovascular Disease (CVD)
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
The Swedish CardioPulmonary bioImage Study (SCAPIS) is a nationwide, open-access, population-based cohort in Sweden designed to study cardiovascular disease and chronic obstructive pulmonary disease. ...
Detailed Description
The Swedish CArdioPulomonary bioImage Study (SCAPIS) is a national population study in Sweden, where comprehensive examinations have been carried out on 30,000 randomly selected people between 50-64 y...
Eligibility Criteria
Inclusion
- \- Participants from the Swedish CArdioPulomonary bioImage Study (SCAPIS)
Exclusion
- Food allergies or intolerances preventing consumption of any products included in the study
- Bariatric surgery, gastric bypass, or sleeve.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
4387 Patients enrolled
Trial Details
Trial ID
NCT06992921
Start Date
January 1 2024
End Date
December 31 2025
Last Update
May 28 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Region Västerbotten (Kliniskt Forskningscentrum)
Umeå, Västerbotten County, Sweden, 901 85
2
Sahlgrenska University Hospital (Östra Hospital)
Gothenburg, Västra Götaland County, Sweden, 416 50